Sanofi rare disease drug hits another setback

Retrieved on: 2021-06-01 15:11:15

Tags for this article:

Medical specialties

Rare diseases

Lipid storage disorders

Lysosomal storage diseases

Genzyme

Autosomal dominant polycystic kidney disease

Lysosomal storage disease

GM2 gangliosidoses

Click the tags to see associated articles and topics

Sanofi rare disease drug hits another setback. View article details on HISWAI: https://www.biopharmadive.com/news/sanofi-venglustat-study-stopped-kidney-disease/601045/

Excerpt

An FDA decision on the latter was recently delayed by three months, to Aug. 18. Recommended Reading: BioPharma Dive A gene therapy pipeline ...

Article found on: www.biopharmadive.com

View Original Article